GLGT

 
Common Stock
OTC Pink No Information
Contact Info
  • 2360 Corporate Circle
  • Suite 400
  • Henderson, NV 89074


Update Company Info
Business Description

Global General Technologies Inc. operates one main subsidiary: AB (Wuhan) Biotech Co. Ltd.AB (Wuhan) Biotech Co. Ltd. is committed to developing, commercializing and popularizing advanced In Vitro Diagnostic (IVD) kits/devices to improve human health.
The company's primary business is to design, develop, patent and market home-applicable diagnostic test kits and portable diagnostic devices related to cardiovascular diseases and infectious diseases, specifically for the early detection of a...

More >>

 
Financial Reporting/Disclosure
Reporting Status Dark
Deregistered a/o Apr 28, 2009
Audited Financials Audited
Latest Report Nov 16, 2009 Quarterly Report
Regulatory Agency Not Available
CIK 0001092455
Fiscal Year End 12/31
OTC Market Tier OTC Pink No Information
Profile Data
SIC - Industry Classification 8000 - Services-Health Services
Business Status Development Stage Company a/o Jun 17, 2008
Incorporated In: NV, USA
Year of Inc. Not Available
Employees 12 a/o Sep 10, 2009
Company Officers
Jim Qian CEO
Dewu Xiong CFO
Phillip Welsh Secretary
Amy Liao VP, R&D
Yong Qian VP, Sales
Company Directors
Not Available
Company Notes
  • Formerly=Knowledge Transfer Systems Inc. until 7-05
  • Formerly=Go Think.com, Inc. until 4-01
  • Formerly=Think!.com, Inc. until 6-99
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
GLGT Security Details
Share Structure
Market Value1 $80,308 a/o May 15, 2012
Shares Outstanding 803,075,764 a/o Nov 24, 2010
Float 245,800,000 a/o Sep 10, 2009
Authorized Shares 950,000,000 a/o Sep 30, 2009
Par Value 0.001
Shareholders
Shareholders of Record 300 a/o May 15, 2008
Short Selling Data
Short Interest 0 (-100%)
Jul 15, 2011
Significant Failures to Deliver No
Transfer Agent(s)
Heritage Transfer Agency

1Market Value calculated only for respective security